Nykredit A S Buys New Shares in Corteva, Inc. $CTVA

Key Points

• Nykredit A/S acquired 159,702 Corteva shares during the second quarter, valued at approximately $13.5 million. Institutional investors collectively own 81.54% of the company.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, though revenue of $6.38 billion declined 1.2% year over year and missed expectations.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $91.90 versus the stock’s reported price of $80.48; Corteva also pays a $0.18 quarterly dividend.

Nykredit A S acquired a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 159,702 shares of the company's stock, valued at approximately $13,525,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust lifted its position in Corteva by 3.2% during the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company's stock worth $316,000 after acquiring an additional 116 shares in the last quarter. HighTower Advisors LLC grew its holdings in Corteva by 3.1% during the 2nd quarter. HighTower Advisors LLC now owns 235,456 shares of the company's stock worth $19,941,000 after acquiring an additional 7,037 shares in the last quarter. Ameritas Advisory Services LLC bought a new stake in Corteva in the second quarter valued at about $297,000. Wedmont Private Capital raised its stake in Corteva by 50.2% during the second quarter. Wedmont Private Capital now owns 7,858 shares of the company's stock valued at $673,000 after buying an additional 2,625 shares in the last quarter. Finally, HB Wealth Management LLC raised its position in shares of Corteva by 0.5% during the 2nd quarter. HB Wealth Management LLC now owns 23,822 shares of the company's stock valued at $2,018,000 after acquiring an additional 128 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

Shares of CTVA stock opened at $80.48 on Friday. The company has a market capitalization of $53.69 billion, a price-to-earnings ratio of 53.30, a P/E/G ratio of 2.47 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The stock's fifty day simple moving average is $83.12 and its 200-day simple moving average is $81.46.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to analysts' expectations of $6.60 billion. During the same period last year, the company posted $2.20 earnings per share. The firm's quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's payout ratio is presently 47.68%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. UBS Group upped their target price on Corteva from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Morgan Stanley lifted their target price on Corteva from $84.00 to $95.00 and gave the company an "overweight" rating in a research note on Thursday, May 28th. Oppenheimer raised their target price on shares of Corteva from $89.00 to $95.00 and gave the company an "outperform" rating in a research note on Thursday, July 23rd. Finally, Bank of America boosted their price objective on Corteva from $90.00 to $96.00 and gave the stock a "buy" rating in a research note on Monday, July 20th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $91.90.

Corteva Profile

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.